MedTrace Logo

Canadian Adult Congenital Heart Disease Intervention Registry

NCT04288596 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 9000

Last updated 2020-02-28

No results posted yet for this study

Summary

The ACHDi Registry study will create a foundational database for adult congenital heart disease interventions. This Pan-Canadian Registry will collect clinical and patient-reported information that will enable the evaluation of care processes and outcomes in five most common ACHDi interventions by enabling prospective and retrospective registry-based studies to answer important clinical practice and policy-relevant questions.

Conditions

  • Atrial Septal Defect
  • Patent Foramen Ovale
  • Tetralogy of Fallot
  • Fontan
  • Coarctation of Aorta
  • Transposition of Great Vessels
  • Percutaneous Pulmonary Valve Implantation

Interventions

OTHER

Participants undergoing ACHD intervention

Participants will receive standard of care for their ACHD intervention.

Sponsors & Collaborators

  • University Health Network, Toronto

    lead OTHER

Principal Investigators

  • Eric Horlick, MD · University Health Network, Peter Munk Cardiac Centre

  • Lusine Abrahamyan, MD, PhD · University Health Network, Theta Collaborative

Eligibility

Min Age
18 Years
Max Age
110 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-01
Primary Completion
2030-04-01
Completion
2030-04-01

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04288596 on ClinicalTrials.gov